SCM
CRVO icon

Soleus Capital Management’s CervoMed CRVO Stock Holding History

Soleus Capital Management’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-126,614
Closed -$1.85M – 90
2024
Q3 		$1.85M Hold
126,614
– – 0.14% 79
2024
Q2 		$2.17M Hold
126,614
– – 0.19% 79
2024
Q1 		$2.95M Buy
+126,614
New +$1.69M 0.22% 73

Other funds holding CRVO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Soleus Capital Management's CRVO Position: Q4 2024 in Review

Soleus Capital Management sold out of CervoMed (CRVO) in Q4 2024, closing a stake of 126,614 shares — an estimated $1.85M sold.

Soleus Capital Management first reported a position in CRVO in Q1 2024 and held it in 3 quarters. The position peaked at $2.95M in Q1 2024. 49 funds tracked by Wall St. Rank hold CRVO as of Q4 2024.

  • Soleus Capital Management reported no remaining CervoMed position as of Q4 2024 after selling out during the quarter.
  • Soleus Capital Management sold 126,614 CervoMed shares in Q4 2024, an estimated $1.85M.
  • Soleus Capital Management first reported a position in CervoMed in Q1 2024 and held it in 3 quarters.
  • Soleus Capital Management's CervoMed position peaked at $2.95M in Q1 2024.
  • 49 funds tracked by Wall St. Rank held CervoMed as of Q4 2024.

Based on Soleus Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.